Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Moderna (NASDAQ:MRNA) will report third quarter 2025 financial results on Thursday, November 6, 2025 with a live conference call and webcast at 8:00 a.m. ET.
The live webcast will be available under "Events and Presentations" in the Investors section of Moderna's website at https://investors.modernatx.com. An archived webcast will be posted about two hours after the call and will remain available for one year.
Moderna (NASDAQ:MRNA) riferirà i risultati finanziari del terzo trimestre 2025 giovedì 6 novembre 2025 con una conference call in diretta e webcast alle 8:00 ET.
Il webcast in diretta sarà disponibile sotto "Eventi e Presentazioni" nella sezione Investitori del sito Moderna all'URL https://investors.modernatx.com. Una versione registrata del webcast sarà pubblicata circa due ore dopo la chiamata e resterà disponibile per un anno.
Moderna (NASDAQ:MRNA) publicará los resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025 con una llamada de conferencia en vivo y transmisión web a las 8:00 a. m. hora del Este.
La transmisión web en vivo estará disponible bajo "Eventos y Presentaciones" en la sección de Inversores del sitio de Moderna en https://investors.modernatx.com. Se subirá una transmisión web archivada aproximadamente dos horas después de la llamada y estará disponible durante un año.
Moderna (NASDAQ:MRNA)은 2025년 3분기 재무 실적을 2025년 11월 6일 목요일에 발표하며 미 동부 표준시 오전 8:00에 라이브 컨퍼런스 콜 및 웹캐스트를 진행합니다.
라이브 웹캐스트는 Moderna 웹사이트의 투자자 섹션의 "Events and Presentations"에서 https://investors.modernatx.com으로 제공됩니다. 콜 이후 약 두 시간 정도 뒤에 아카이브 웹캐스트가 게시되며 1년 동안 이용 가능하게 됩니다.
Moderna (NASDAQ:MRNA) rendra publics les résultats financiers du troisième trimestre 2025 le jeudi 6 novembre 2025 lors d'une conférence téléphonique en direct et d'un webcast à 8h00, heure de l'Est.
Le webcast en direct sera disponible sous « Événements et présentations » dans la section Investisseurs du site de Moderna à l'adresse https://investors.modernatx.com. Une version archivisée du webcast sera publiée environ deux heures après l'appel et restera disponible pendant un an.
Moderna (NASDAQ:MRNA) wird die Finanzergebnisse für das dritte Quartal 2025 am Donnerstag, 6. November 2025 mit einer Live-Konferenzschaltung und einem Webcast um 8:00 a. m. ET bekannt geben.
Der Live-Webcast ist unter "Events und Präsentationen" im Bereich Investor Relations der Moderna-Website unter der URL https://investors.modernatx.com verfügbar. Ein archivierter Webcast wird etwa zwei Stunden nach dem Anruf veröffentlicht und bleibt ein Jahr lang verfügbar.
مودِرنا (NASDAQ:MRNA) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 يوم الخميس 6 نوفمبر 2025 مع مكالمة مؤتمَر مباشر وبث حي في 8:00 صباحًا بتوقيت شرق الولايات المتحدة.
سيكون البث المباشر متاحًا ضمن "الأحداث والعروض" في قسم المستثمرين على موقع Moderna على العنوان https://investors.modernatx.com. سيُنشَر بث مسجَّل بعد حوالي ساعتين من المكالمة وسيظل متاحًا لمدة عام.
Moderna (NASDAQ:MRNA) 将在2025年第三季度于2025年11月6日，星期四公布财务业绩并进行美东时间上午8:00的现场电话会议和网络直播。
现场网络直播将在 Moderna 网站的投资者栏目中的“活动与演示”下提供，网址为https://investors.modernatx.com。一个归档版本的网络直播将在通话后约两个小时发布，并将持续一年。
- None.
- None.
CAMBRIDGE, MA, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Moderna (MRNA) report Q3 2025 results?
How can I listen to Moderna's (MRNA) Q3 2025 earnings call?
Will Moderna (MRNA) provide an archived webcast of the Q3 2025 call?
What time is Moderna's (MRNA) Q3 2025 conference call?
Where on Moderna's site is the webcast for the Q3 2025 results?
Will the Q3 2025 Moderna (MRNA) archived webcast remain available long-term?
